Report Detail
Global Traveler's Diarrhea Therapeutics Market Growth 2019-2024
- RnM2799084 |
- 23 January, 2019 |
- Global |
- 139 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Traveler's diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week.
Traveler’s diarrhea is the leading cause of illness among international travelers to developing countries. Enterotoxigenic Escherichia coli (ETEC) bacteria are the primary cause of this disease. Among the estimated 65 million travelers from industrialized countries to high-risk areas in the developing world, as many as 50% may experience at least one TD episode during their journey. ETEC is usually responsible for 22-60% of all TD cases in both civilian and military groups or about 7-18 million cases per year. ETEC is also a major cause of diarrheal disease in children living in countries endemic for ETEC, leading to over 400 million diarrheal episodes and approximately 300,000 deaths each year.
The classification of Traveler’s Diarrhea Therapeutics includes Immunization, Non-antibiotic Agents, Antibiotics, Anti-Motility Agents, Other. And the proportion of Non-antibiotic Agents in 2017 is about 36%, and And the proportion of Anti-Motility Agents in 2017 is about 20%.
According to this study, over the next five years the Traveler's Diarrhea Therapeutics market will register a 7.1% CAGR in terms of revenue, the global market size will reach US$ 890 million by 2024, from US$ 630 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Traveler's Diarrhea Therapeutics business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Traveler's Diarrhea Therapeutics market by product type, application, key manufacturers and key regions and countries.
This study considers the Traveler's Diarrhea Therapeutics value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Immunization
Non-antibiotic Agents
Antibiotics
Anti-Motility Agents
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Adult Traveler's Diarrhea
Children Traveler's Diarrhea
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Salix Pharmaceuticals
P&G
Johnson & Johnson
Otsuka Pharma
Valneva
Shanghai United Cell
PaxVax
Livzon
Immuron
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Traveler's Diarrhea Therapeutics consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Traveler's Diarrhea Therapeutics market by identifying its various subsegments.
Focuses on the key global Traveler's Diarrhea Therapeutics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Traveler's Diarrhea Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Traveler's Diarrhea Therapeutics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Traveler's Diarrhea Therapeutics Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Traveler's Diarrhea Therapeutics Consumption 2014-2024
- 2.1.2 Traveler's Diarrhea Therapeutics Consumption CAGR by Region
- 2.2 Traveler's Diarrhea Therapeutics Segment by Type
- 2.2.1 Immunization
- 2.2.2 Non-antibiotic Agents
- 2.2.3 Antibiotics
- 2.2.4 Anti-Motility Agents
- 2.2.5 Other
- 2.3 Traveler's Diarrhea Therapeutics Consumption by Type
- 2.3.1 Global Traveler's Diarrhea Therapeutics Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Traveler's Diarrhea Therapeutics Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Traveler's Diarrhea Therapeutics Sale Price by Type (2014-2019)
- 2.4 Traveler's Diarrhea Therapeutics Segment by Application
- 2.4.1 Adult Traveler's Diarrhea
- 2.4.2 Children Traveler's Diarrhea
- 2.5 Traveler's Diarrhea Therapeutics Consumption by Application
- 2.5.1 Global Traveler's Diarrhea Therapeutics Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Traveler's Diarrhea Therapeutics Value and Market Share by Application (2014-2019)
- 2.5.3 Global Traveler's Diarrhea Therapeutics Sale Price by Application (2014-2019)
3 Global Traveler's Diarrhea Therapeutics by Players
- 3.1 Global Traveler's Diarrhea Therapeutics Sales Market Share by Players
- 3.1.1 Global Traveler's Diarrhea Therapeutics Sales by Players (2017-2019)
- 3.1.2 Global Traveler's Diarrhea Therapeutics Sales Market Share by Players (2017-2019)
- 3.2 Global Traveler's Diarrhea Therapeutics Revenue Market Share by Players
- 3.2.1 Global Traveler's Diarrhea Therapeutics Revenue by Players (2017-2019)
- 3.2.2 Global Traveler's Diarrhea Therapeutics Revenue Market Share by Players (2017-2019)
- 3.3 Global Traveler's Diarrhea Therapeutics Sale Price by Players
- 3.4 Global Traveler's Diarrhea Therapeutics Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Traveler's Diarrhea Therapeutics Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Traveler's Diarrhea Therapeutics Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Traveler's Diarrhea Therapeutics by Regions
- 4.1 Traveler's Diarrhea Therapeutics by Regions
- 4.1.1 Global Traveler's Diarrhea Therapeutics Consumption by Regions
- 4.1.2 Global Traveler's Diarrhea Therapeutics Value by Regions
- 4.2 Americas Traveler's Diarrhea Therapeutics Consumption Growth
- 4.3 APAC Traveler's Diarrhea Therapeutics Consumption Growth
- 4.4 Europe Traveler's Diarrhea Therapeutics Consumption Growth
- 4.5 Middle East & Africa Traveler's Diarrhea Therapeutics Consumption Growth
5 Americas
- 5.1 Americas Traveler's Diarrhea Therapeutics Consumption by Countries
- 5.1.1 Americas Traveler's Diarrhea Therapeutics Consumption by Countries (2014-2019)
- 5.1.2 Americas Traveler's Diarrhea Therapeutics Value by Countries (2014-2019)
- 5.2 Americas Traveler's Diarrhea Therapeutics Consumption by Type
- 5.3 Americas Traveler's Diarrhea Therapeutics Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Traveler's Diarrhea Therapeutics Consumption by Countries
- 6.1.1 APAC Traveler's Diarrhea Therapeutics Consumption by Countries (2014-2019)
- 6.1.2 APAC Traveler's Diarrhea Therapeutics Value by Countries (2014-2019)
- 6.2 APAC Traveler's Diarrhea Therapeutics Consumption by Type
- 6.3 APAC Traveler's Diarrhea Therapeutics Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Traveler's Diarrhea Therapeutics by Countries
- 7.1.1 Europe Traveler's Diarrhea Therapeutics Consumption by Countries (2014-2019)
- 7.1.2 Europe Traveler's Diarrhea Therapeutics Value by Countries (2014-2019)
- 7.2 Europe Traveler's Diarrhea Therapeutics Consumption by Type
- 7.3 Europe Traveler's Diarrhea Therapeutics Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Traveler's Diarrhea Therapeutics by Countries
- 8.1.1 Middle East & Africa Traveler's Diarrhea Therapeutics Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Traveler's Diarrhea Therapeutics Value by Countries (2014-2019)
- 8.2 Middle East & Africa Traveler's Diarrhea Therapeutics Consumption by Type
- 8.3 Middle East & Africa Traveler's Diarrhea Therapeutics Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.2 Traveler's Diarrhea Therapeutics Distributors
- 10.3 Traveler's Diarrhea Therapeutics Customer
11 Global Traveler's Diarrhea Therapeutics Market Forecast
- 11.1 Global Traveler's Diarrhea Therapeutics Consumption Forecast (2019-2024)
- 11.2 Global Traveler's Diarrhea Therapeutics Forecast by Regions
- 11.2.1 Global Traveler's Diarrhea Therapeutics Forecast by Regions (2019-2024)
- 11.2.2 Global Traveler's Diarrhea Therapeutics Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Traveler's Diarrhea Therapeutics Forecast by Type
- 11.8 Global Traveler's Diarrhea Therapeutics Forecast by Application
12 Key Players Analysis
- 12.1 Salix Pharmaceuticals
- 12.1.1 Company Details
- 12.1.2 Traveler's Diarrhea Therapeutics Product Offered
- 12.1.3 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Salix Pharmaceuticals News
- 12.2 P&G
- 12.2.1 Company Details
- 12.2.2 Traveler's Diarrhea Therapeutics Product Offered
- 12.2.3 P&G Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 P&G News
- 12.3 Johnson & Johnson
- 12.3.1 Company Details
- 12.3.2 Traveler's Diarrhea Therapeutics Product Offered
- 12.3.3 Johnson & Johnson Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Johnson & Johnson News
- 12.4 Otsuka Pharma
- 12.4.1 Company Details
- 12.4.2 Traveler's Diarrhea Therapeutics Product Offered
- 12.4.3 Otsuka Pharma Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Otsuka Pharma News
- 12.5 Valneva
- 12.5.1 Company Details
- 12.5.2 Traveler's Diarrhea Therapeutics Product Offered
- 12.5.3 Valneva Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Valneva News
- 12.6 Shanghai United Cell
- 12.6.1 Company Details
- 12.6.2 Traveler's Diarrhea Therapeutics Product Offered
- 12.6.3 Shanghai United Cell Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Shanghai United Cell News
- 12.7 PaxVax
- 12.7.1 Company Details
- 12.7.2 Traveler's Diarrhea Therapeutics Product Offered
- 12.7.3 PaxVax Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 PaxVax News
- 12.8 Livzon
- 12.8.1 Company Details
- 12.8.2 Traveler's Diarrhea Therapeutics Product Offered
- 12.8.3 Livzon Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Livzon News
- 12.9 Immuron
- 12.9.1 Company Details
- 12.9.2 Traveler's Diarrhea Therapeutics Product Offered
- 12.9.3 Immuron Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Immuron News
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Traveler's Diarrhea Therapeutics . Industry analysis & Market Report on Traveler's Diarrhea Therapeutics is a syndicated market report, published as Global Traveler's Diarrhea Therapeutics Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Traveler's Diarrhea Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
